A circadian rhythm-related biomarker for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma

Lung adenocarcinoma (LUAD) remains a major reason of cancer-associated mortality globally, and there exists a lack of indicators for survival in LUAD patients. Therefore, it is clinically required to obtain a novel prognostically indicator for guiding clinical management. In this study, we establish...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Yuanjun, Yao, Jie, Fang, Qianru, Chen, Bin, Zang, Guohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792196/
https://www.ncbi.nlm.nih.gov/pubmed/36455876
http://dx.doi.org/10.18632/aging.204411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792196/
https://www.ncbi.nlm.nih.gov/pubmed/36455876
http://dx.doi.org/10.18632/aging.204411

Ejemplares similares